Dydrogesterone
Who holds supplier records for Dydrogesterone? 7 organisations hold a current record for Dydrogesterone: an active US FDA Type II Drug Master File or a CEP. A further 1 organisation has only historical (inactive) DMF filings. 6 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (3), China (2) and Netherlands (1); not recorded for 1.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Dydrogesterone: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/dydrogesterone
Reading the evidence
- 7 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 2 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (7)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Dydrogesterone. Country is the organisation's recorded country, not necessarily the manufacturing site.
- ARESKO LIFE SCIENCES PRIVATE LIMITEDIndiaCEPActive DMF 43148 · latest filing Mar 2026
- Yangzhou Aurisco Pharmaceutical Co.,Ltd.ChinaCEPActive DMF 36569 · latest filing Jan 2022
- XIAN GUOKANG RUIJIN PHARMACEUTICAL CO LTDActive DMF 36271 · latest filing Apr 2022
- IndiaCEP Company GMP cert on record
- Hunan KYF Pharmaceutical. Co., LtdChinaCEP
- IndiaCEP Company GMP cert on record
- ABBOTT HEALTHCARE PRODUCTS B.V.NetherlandsCEPValid CEP holder (EDQM); not necessarily the manufacturer
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (6)
Certificates of Suitability on the EDQM register for Dydrogesterone, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 7 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| YANGZHOU AURISCO PHARMACEUTICAL CO., LTD. Yangzhou | CN | CEP 2021-460 - Rev 04 Dydrogesterone, Micronised | Oct 2026 | — |
| ARESKO LIFE SCIENCES PRIVATE LIMITED Ramnagar | IN | CEP 2024-408 - Rev 00 Dydrogesterone | Sept 2026 | — |
| HUNAN KYF PHARMACEUTICAL CO., LTD Jinshi | CN | CEP 2025-338 - Rev 00 Dydrogesterone, Micronised | Sept 2026 | — |
| EMCURE PHARMACEUTICALS LIMITED Pune | IN | CEP 2025-143 - Rev 00 Dydrogesterone | Jun 2026 | — |
| MANKIND PHARMA LIMITED New Delhi | IN | CEP 2024-196 - Rev 00 Dydrogesterone, Micronised | Nov 2025 | — |
| ABBOTT HEALTHCARE PRODUCTS B.V. Weesp | NL | CEP 2019-114 - Rev 01 Dydrogesterone, Micronised | Apr 2024 | Inspected Mar 2024 Netherlands |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (1)
Organisations whose Type II DMFs for Dydrogesterone are no longer active. These show a past filing, not current supply.
Show all 1 historical record
- DUPHAR BVInactive DMF 427 · filed Apr 1961
Overview
Dydrogesterone is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1200853).
Chemical identity
- IUPAC name
- (8S,9R,10S,13S,14S,17S)-17-acetyl-10,13-dimethyl-1,2,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-one
- Canonical SMILES
- CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@@H]3[C@H]2C=CC4=CC(=O)CC[C@@]34C)C
- InChIKey
- JGMOKGBVKVMRFX-HQZYFCCVSA-N
- Synonyms
- Didrogesterona, Duphaston, Duphaston-hrt, Dydrogesterone, Gynorest, Isopregnenone, NSC-92336, Hydrogesterone, Hydrogestrone, Gestatron, Retrone, Diphaston
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Dydrogesterone?
7 organisations hold an active US FDA Type II Drug Master File or a CEP for Dydrogesterone: ARESKO LIFE SCIENCES PRIVATE LIMITED (India), Yangzhou Aurisco Pharmaceutical Co.,Ltd. (China), XIAN GUOKANG RUIJIN PHARMACEUTICAL CO LTD, Emcure Pharmaceuticals Limited (India), Hunan KYF Pharmaceutical. Co., Ltd (China), Mankind Pharma Limited (India) and ABBOTT HEALTHCARE PRODUCTS B.V. (Netherlands). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Dydrogesterone Drug Master Files are active?
ARESKO LIFE SCIENCES PRIVATE LIMITED (DMF 43148), Yangzhou Aurisco Pharmaceutical Co.,Ltd. (DMF 36569) and XIAN GUOKANG RUIJIN PHARMACEUTICAL CO LTD (DMF 36271). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Dydrogesterone records mean?
1 organisation has only inactive Type II DMFs for Dydrogesterone. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Dydrogesterone have a European Certificate of Suitability?
Yes. 6 organisations hold a valid CEP for Dydrogesterone on the EDQM register, including YANGZHOU AURISCO PHARMACEUTICAL CO., LTD. Yangzhou (CN), ARESKO LIFE SCIENCES PRIVATE LIMITED Ramnagar (IN), HUNAN KYF PHARMACEUTICAL CO., LTD Jinshi (CN), EMCURE PHARMACEUTICALS LIMITED Pune (IN), MANKIND PHARMA LIMITED New Delhi (IN) and ABBOTT HEALTHCARE PRODUCTS B.V. Weesp (NL). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Dydrogesterone supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Dydrogesterone?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.